{"id":182764,"date":"2026-02-15T20:19:16","date_gmt":"2026-02-15T17:19:16","guid":{"rendered":"https:\/\/medclinics.com\/multipl-skleroz-ms-istanbul-turkiyede-kok-hucre-ve-ekzozom-tedavisi\/"},"modified":"2026-02-25T16:18:58","modified_gmt":"2026-02-25T13:18:58","slug":"multipl-skleroz-kok-hucre-eksozom-tedavisi-istanbul","status":"publish","type":"post","link":"https:\/\/medclinics.com\/tr\/multipl-skleroz-kok-hucre-eksozom-tedavisi-istanbul\/","title":{"rendered":"Multipl Skleroz (MS) \u2013 \u0130stanbul, T\u00fcrkiye&#8217;de K\u00f6k H\u00fccre ve Ekzozom Tedavisi"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\" id=\"understanding-copd-and-the-role-of-regenerative-therapy\">MS&#8217;i Anlamak \u2013 Multipl Skleroz \u2013 ve Hastalar \u0130\u00e7in Rejeneratif Tedavinin Rol\u00fc<\/h2>\n\n\n\n<p><em><strong>Klinik Bulgular Prof. Dr. Serdar Kabata\u015f, MD, PhD (C)<\/strong><\/em><\/p>\n\n\n\n<p>Multipl skleroz neredeyse hi\u00e7bir zaman kesin olarak ba\u015flamaz. <br>Rejeneratif tedavinin multipl sklerozda nas\u0131l bir rol oynayabilece\u011fini anlamak i\u00e7in, \u00f6ncelikle hastal\u0131\u011f\u0131n kendisinin nas\u0131l davrand\u0131\u011f\u0131n\u0131 ve ilerledi\u011fini anlamak gerekir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"a-personal-perspective-from-a-neurosurgeon-and-stem-cell-immunology-specialist\">Bir beyin cerrah\u0131 ve k\u00f6k h\u00fccre ve imm\u00fcnoloji uzman\u0131n\u0131n ki\u015fisel bak\u0131\u015f a\u00e7\u0131s\u0131<\/h2>\n\n\n\n<p> Ben Prof. Dr. Serdar Kabata\u015f.<\/p>\n\n\n\n<p>Uzun y\u0131llard\u0131r merkezi sinir sistemi hastal\u0131klar\u0131 \u00fczerinde \u00e7al\u0131\u015f\u0131yorum ve multipl skleroz, hastalar\u0131n bekledi\u011fi \u015fekilde seyreden nadir hastal\u0131klardan biridir.<br>Bunun nedeni, hastal\u0131\u011f\u0131n gizemli olmas\u0131 de\u011fil, yava\u015f ilerlemesidir. Genellikle sessizce ilerler. Bazen tek bir muayenede a\u00e7\u0131klamas\u0131 zor \u015fekillerde ilerler.  <\/p>\n\n\n\n<p>Multipl Sklerozu \u00f6zellikle zorlu k\u0131lan \u015fey, sadece iltihaplanma veya MRG&#8217;de g\u00f6r\u00fclen lezyonlar de\u011fildir. Hastalar\u0131n belirsizlik i\u00e7inde ya\u015fad\u0131klar\u0131 uzun s\u00fcreli d\u00f6nemdir \u2014 aktif hissettikleri a\u015famalar ile stabil g\u00f6r\u00fcnen a\u015famalar aras\u0131nda, sinir sisteminde ger\u00e7ekte neler olup bitti\u011finden hi\u00e7bir zaman tam olarak emin olamadan. <\/p>\n\n\n\n<p>Y\u0131llar boyunca, tan\u0131dan \u00e7ok basit bir soruya odaklanan bir\u00e7ok hasta ile kar\u015f\u0131la\u015ft\u0131m: Hala etkilenebilecek bir \u015fey var m\u0131?<br>Bu genellikle rejeneratif yakla\u015f\u0131mlar\u0131n tart\u0131\u015fmaya girdi\u011fi noktad\u0131r. K\u00f6k h\u00fccreler. Ekzozomlar. Biyolojik destek tedavileri. Genellikle umutla, ama ayn\u0131 s\u0131kl\u0131kta kafa kar\u0131\u015f\u0131kl\u0131\u011f\u0131yla da e\u015flik eder.    <\/p>\n\n\n\n<p>Benim sorumlulu\u011fum, her \u015feyden \u00f6nce, ba\u015fka bir se\u00e7enek sunmak de\u011fil, bu yakla\u015f\u0131mlar\u0131 n\u00f6rolojik bir ba\u011flama oturtmak, yani bunlar\u0131n nerede rol oynayabilece\u011fini ve nerede a\u00e7\u0131k\u00e7a rol oynayamayaca\u011f\u0131n\u0131 a\u00e7\u0131klamakt\u0131r.<\/p>\n\n\n\n<p>Bu makale bu ama\u00e7la yaz\u0131lm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u0130yile\u015fme s\u00f6z\u00fc vermemek.<\/li>\n\n\n\n<li>Yerle\u015fik MS tedavilerinin de\u011fi\u015ftirilmesini \u00f6nermek de\u011fildir.<\/li>\n\n\n\n<li>Ancak, rejeneratif t\u0131bb\u0131n multipl sklerozda biyolojik olarak ne zaman hala anlaml\u0131 olabilece\u011fini ve ne zaman art\u0131k anlaml\u0131 olmayaca\u011f\u0131n\u0131 sakin ve d\u00fcr\u00fcst bir \u015fekilde a\u00e7\u0131klamak gerekir.<\/li>\n<\/ul>\n\n\n\n<p>\u00c7\u00fcnk\u00fc multipl sklerozda, di\u011fer bir\u00e7ok n\u00f6rolojik hastal\u0131ktan daha fazla, zamanlama bir ayr\u0131nt\u0131 de\u011fildir.<br>Bu, belirleyici fakt\u00f6rd\u00fcr.<\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler Tablosu<\/h2><nav><ul><li><a href=\"#understanding-copd-and-the-role-of-regenerative-therapy\">MS&#8217;i Anlamak \u2013 Multipl Skleroz \u2013 ve Hastalar \u0130\u00e7in Rejeneratif Tedavinin Rol\u00fc<\/a><\/li><li><a href=\"#a-personal-perspective-from-a-neurosurgeon-and-stem-cell-immunology-specialist\">Bir beyin cerrah\u0131 ve k\u00f6k h\u00fccre ve imm\u00fcnoloji uzman\u0131n\u0131n ki\u015fisel bak\u0131\u015f a\u00e7\u0131s\u0131<\/a><\/li><li><a href=\"#multiple-sclerosis-is-not-one-disease-but-a-spectrum-of-course\">Multipl Skleroz Tek Bir Hastal\u0131k De\u011fil, Bir Spektrumdur<\/a><\/li><li><a href=\"#relapsing-remitting-multiple-sclerosis-the-phase-where-inflammation-dominates\">N\u00fckseden-Remisyonlu Multipl Skleroz: Enflamasyonun Hakim Oldu\u011fu A\u015fama<\/a><\/li><li><a href=\"#secondary-progressive-multiple-sclerosis-when-damage-becomes-less-reversible\">\u0130kincil Progresif Multipl Skleroz: Hasar\u0131n Geri D\u00f6n\u00fc\u015f\u00fcms\u00fcz Hale Geldi\u011fi Durumlar<\/a><\/li><li><a href=\"#primary-progressive-multiple-sclerosis-a-fundamentally-different-disease-course\">Birincil Progresif Multipl Skleroz: Temelde Farkl\u0131 Bir Hastal\u0131k Seyri<\/a><\/li><li><a href=\"#why-timing-matters-more-than-the-ms-diagnosis-itself\">Zamanlama Neden MS Tan\u0131s\u0131ndan Daha \u00d6nemlidir?<\/a><\/li><li><a href=\"#mri-imaging-in-multiple-sclerosis-a-mandatory-requirement-before-any-therapy\">Multipl Sklerozda MRG G\u00f6r\u00fcnt\u00fcleme: Herhangi Bir Tedavi \u00d6ncesi Zorunlu Bir Gereklilik<\/a><\/li><li><a href=\"#why-stem-cell-therapy-is-discussed-in-multiple-sclerosis\">Neden K\u00f6k H\u00fccre Tedavisi Multipl Sklerozda Tart\u0131\u015f\u0131l\u0131yor?<\/a><\/li><li><a href=\"#exosome-therapy-in-multiple-sclerosis-biological-signaling-rather-than-replacement\">Multipl Sklerozda Ekzozom Tedavisi: Yerine Koyma Yerine Biyolojik Sinyalle\u015fme<\/a><\/li><li><a href=\"#when-regenerative-therapy-in-ms-reaches-its-biological-limits\">MS&#8217;te Rejeneratif Tedavi Biyolojik S\u0131n\u0131rlar\u0131na Ula\u015ft\u0131\u011f\u0131nda<\/a><\/li><li><a href=\"#which-multiple-sclerosis-patients-may-be-considered-for-regenerative-therapy\">Hangi Multipl Skleroz Hastalar\u0131 Rejeneratif Tedavi i\u00e7in De\u011ferlendirilebilir?<\/a><\/li><li><a href=\"#medical-evaluation-required-before-regenerative-therapy-in-ms\">MS&#8217;de Rejeneratif Tedavi \u00d6ncesi T\u0131bbi De\u011ferlendirme Gereklidir<\/a><\/li><li><a href=\"#how-regenerative-therapy-is-applied-in-clinical-practice\">Rejeneratif Terapi Klinik Uygulamada Nas\u0131l Kullan\u0131l\u0131r?<\/a><\/li><li><a href=\"#safety-and-ethical-standards-in-regenerative-ms-therapy\">Rejeneratif MS Tedavisinde G\u00fcvenlik ve Etik Standartlar<\/a><\/li><li><a href=\"#what-ms-patients-may-experience-after-regenerative-therapy\">Rejeneratif Tedavi Sonras\u0131 MS Hastalar\u0131n\u0131n Ya\u015fayabilece\u011fi Deneyimler<\/a><\/li><li><a href=\"#a-clinical-perspective-on-regenerative-therapy-in-multiple-sclerosis\">Multipl Sklerozda Rejeneratif Tedaviye Klinik Bir Bak\u0131\u015f<\/a><\/li><li><a href=\"#frequently-asked-questions-stem-cell-exosome-therapy-for-copd\">S\u0131k\u00e7a Sorulan Sorular \u2013 MS i\u00e7in K\u00f6k H\u00fccre ve Ekzozom Tedavisi &#8211; Multipl Skleroz<\/a><ul><\/ul><\/li><\/ul><\/nav><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"multiple-sclerosis-is-not-one-disease-but-a-spectrum-of-course\">Multipl Skleroz Tek Bir Hastal\u0131k De\u011fil, Bir Spektrumdur<\/h2>\n\n\n\n<p>G\u00fcnl\u00fck konu\u015fmalarda MS genellikle tek bir hastal\u0131k olarak ele al\u0131n\u0131r. Ancak klinik ger\u00e7eklikte durum b\u00f6yle de\u011fildir.<br>N\u00f6rologlar, hastal\u0131\u011f\u0131n seyrinde farkl\u0131l\u0131klar\u0131n oldu\u011funu belirtirler, \u00e7\u00fcnk\u00fc hastal\u0131\u011f\u0131n ilerleyi\u015finde hasara yol a\u00e7an mekanizmalar ayn\u0131 de\u011fildir. Sinir sistemi her a\u015famada ayn\u0131 \u015fekilde tepki vermez. Erken a\u015famalarda biyolojik olarak etkilenebilen fakt\u00f6rler, ilerleyen a\u015famalarda giderek sabit hale gelir.   <\/p>\n\n\n\n<p>Bu ayr\u0131m \u00f6nemlidir.<br>T\u0131bbi a\u00e7\u0131dan \u00f6nemlidir. Ve hastalar i\u00e7in duygusal a\u00e7\u0131dan da \u00f6nemlidir. <\/p>\n\n\n\n<p>MS genel olarak \u00fc\u00e7 ana t\u00fcre ayr\u0131l\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>N\u00fckseden-remisyonlu MS.<\/li>\n\n\n\n<li>\u0130kincil ilerleyici MS.<\/li>\n\n\n\n<li>Birincil ilerleyici MS.<\/li>\n<\/ul>\n\n\n\n<p>Bunlar akademik tan\u0131mlar de\u011fildir. Hastal\u0131\u011f\u0131n zaman i\u00e7inde nas\u0131l seyretti\u011fini ve m\u00fcdahale i\u00e7in ne kadar alan kald\u0131\u011f\u0131n\u0131 a\u00e7\u0131klar. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"relapsing-remitting-multiple-sclerosis-the-phase-where-inflammation-dominates\">N\u00fckseden-Remisyonlu Multipl Skleroz: Enflamasyonun Hakim Oldu\u011fu A\u015fama<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"760\" height=\"507\" src=\"https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/Relapsing-Remitting-Multiple-Sclerosis-Inflammatory-Phase.webp\" alt=\"N\u00fckseden remisyona giren multipl sklerozda dalgalanan sinir sinyalleri ve iltihab\u0131 g\u00f6steren soyut ill\u00fcstrasyon\" class=\"wp-image-182040\" srcset=\"https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/Relapsing-Remitting-Multiple-Sclerosis-Inflammatory-Phase.webp 760w, https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/Relapsing-Remitting-Multiple-Sclerosis-Inflammatory-Phase-300x200.webp 300w\" sizes=\"(max-width: 760px) 100vw, 760px\" \/><\/figure>\n\n\n\n<p>N\u00fckseden-remisyonlu MS genellikle tan\u0131 an\u0131nda g\u00f6r\u00fclen formdur.<br>Hastalar n\u00fcksler ya\u015farlar. N\u00f6rolojik semptomlar\u0131n belirgin \u015fekilde k\u00f6t\u00fcle\u015fti\u011fi d\u00f6nemler. G\u00fc\u00e7s\u00fczl\u00fck. Duyusal bozukluklar. G\u00f6rme sorunlar\u0131. Denge veya koordinasyon sorunlar\u0131. Bu d\u00f6nemlerden sonra genellikle iyile\u015fme g\u00f6r\u00fcl\u00fcr. Bazen neredeyse tamamen. Bazen sadece k\u0131smen.        <\/p>\n\n\n\n<p>Hastan\u0131n bak\u0131\u015f a\u00e7\u0131s\u0131ndan, bu a\u015fama \u00f6ng\u00f6r\u00fclemez bir \u015fekilde hissedilir. Semptomlar gelip ge\u00e7er. \u0130yi d\u00f6nemler k\u00f6t\u00fc d\u00f6nemlerle d\u00f6n\u00fc\u015f\u00fcml\u00fc olarak g\u00f6r\u00fcl\u00fcr. Hastal\u0131k dengesiz bir \u015fekilde hissedilir.   <\/p>\n\n\n\n<p>Biyolojik a\u00e7\u0131dan bak\u0131ld\u0131\u011f\u0131nda ise, \u00e7ok \u00f6zel bir \u015fey oluyor.<br>N\u00fcksetme s\u0131ras\u0131nda, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleri kan-beyin bariyerini ge\u00e7erek sinir liflerinin etraf\u0131ndaki yal\u0131t\u0131m tabakas\u0131 olan miyelini sald\u0131r\u0131yor. Bu da sinyal iletimini bozuyor. Sinirler hala oradad\u0131r, ancak ileti\u015fim verimsiz hale gelir.<br>Baz\u0131 hastalar bunun sinirlerin zaten &#8220;tahrip oldu\u011fu&#8221; anlam\u0131na gelip gelmedi\u011fini sorar.<br>\u00c7o\u011fu durumda, tahrip olmam\u0131\u015ft\u0131r.<br>Bu a\u015famada, bir\u00e7ok semptom kal\u0131c\u0131 sinir kayb\u0131ndan de\u011fil, a\u015fa\u011f\u0131dakilerden kaynaklan\u0131r:  <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>iltihaplanma<\/li>\n\n\n\n<li>\u015fi\u015flik<\/li>\n\n\n\n<li>ge\u00e7ici demiyelinizasyon<\/li>\n\n\n\n<li>sinyallerin iletilmesinde bozukluk<\/li>\n<\/ul>\n\n\n\n<p>Di\u011fer bir deyi\u015fle, hasar\u0131n \u00e7o\u011fu hala i\u015flevsel olup, hen\u00fcz tamamen yap\u0131sal de\u011fildir.<br>Bu, hasar\u0131n zarars\u0131z oldu\u011fu anlam\u0131na gelmez. Kendi kendine d\u00fczelece\u011fi anlam\u0131na da gelmez. Ancak sinir sisteminin hala bir dereceye kadar biyolojik tepki verme yetene\u011fini korudu\u011fu anlam\u0131na gelir.  <br>\ud83d\udc49 Bu a\u015famada, destekleyici rejeneratif yakla\u015f\u0131mlar bile tart\u0131\u015f\u0131lmaktad\u0131r.<\/p>\n\n\n\n<p>Biyolojik tedavi d\u00fc\u015f\u00fcn\u00fcl\u00fcrse, bu tedavi n\u00fckseden-remisyonlu a\u015famada d\u00fc\u015f\u00fcn\u00fcl\u00fcr. Daha sonraki a\u015famalar farkl\u0131 davran\u0131r. Biyoloji de\u011fi\u015fir.  <\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"secondary-progressive-multiple-sclerosis-when-damage-becomes-less-reversible\">\u0130kincil Progresif Multipl Skleroz: Hasar\u0131n Geri D\u00f6n\u00fc\u015f\u00fcms\u00fcz Hale Geldi\u011fi Durumlar<\/h2>\n\n\n\n<p>Baz\u0131 hastalarda, tekrarlayan-remisyonlu MS stabil kalmaz. Zamanla, genellikle kademeli olarak, hastal\u0131k davran\u0131\u015f\u0131n\u0131 de\u011fi\u015ftirir. <\/p>\n\n\n\n<p>N\u00fcksler daha az belirgin hale gelir veya tamamen ortadan kalkar. Ancak fonksiyonlar azalmaya devam eder. Y\u00fcr\u00fcmek daha zor hale gelir. Yorgunluk artar. Bili\u015fsel \u00e7aba artar.<br>Bu, ikincil progresif <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=multiple+sclerosis\" target=\"_blank\" rel=\"noreferrer noopener\">MS &#8211; Multipl Skleroz<\/a>dur.    <\/p>\n\n\n\n<p>D\u0131\u015far\u0131dan bak\u0131ld\u0131\u011f\u0131nda, bu a\u015fama daha sakin g\u00f6r\u00fcnebilir. Dramatik sald\u0131r\u0131lar daha azd\u0131r. <\/p>\n\n\n\n<p>\u0130\u00e7eriden bak\u0131ld\u0131\u011f\u0131nda, bir\u00e7ok hasta bunu daha zor olarak alg\u0131lar.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u0130yile\u015fme art\u0131k geri gelmiyor.<\/li>\n\n\n\n<li>Biyolojik olarak odak noktas\u0131 de\u011fi\u015fir.<\/li>\n\n\n\n<li>Enflamasyon daha az bask\u0131n hale gelir.<\/li>\n\n\n\n<li>N\u00f6rodejenerasyon daha \u00f6nemli hale geliyor.<\/li>\n\n\n\n<li>Aksonal kay\u0131p artar. <\/li>\n\n\n\n<li>Sinir a\u011flar\u0131 bozulmu\u015ftur. <\/li>\n\n\n\n<li>Sinir sisteminin telafi etme yetene\u011fi azal\u0131r.<\/li>\n<\/ul>\n\n\n\n<p>Bu a\u015famada, hasar art\u0131k \u00f6ncelikle i\u015flevsel de\u011fildir. Giderek yap\u0131sal hale gelmektedir.<br>Ve yap\u0131sal hasar, sadece sinyal vermekle giderilemez.<br>Dan\u0131\u015fmanl\u0131k g\u00f6r\u00fc\u015fmelerinde, bu genellikle tedavi planlar\u0131ndan \u00e7ok beklentilerin ayarlanmas\u0131 gereken noktad\u0131r. <\/p>\n\n\n\n<p><strong>SPMS&#8217;de rejeneratif tedaviler hala \u015funlar\u0131 yapabilir:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>kalan inflamatuar aktiviteyi etkilemek<\/li>\n\n\n\n<li>se\u00e7ilmi\u015f hastalarda semptom stabilitesini desteklemek<\/li>\n\n\n\n<li>baz\u0131 durumlarda yava\u015f yava\u015f daha da azalma<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kay\u0131p fonksiyonu geri getiremezler.<\/li>\n\n\n\n<li>Y\u0131k\u0131lan yollar\u0131 yeniden in\u015fa edemezler.<\/li>\n\n\n\n<li>Uzun s\u00fcredir devam eden engellili\u011fi geri d\u00f6nd\u00fcremezler.<\/li>\n<\/ul>\n\n\n\n<p>Bu t\u0131bb\u0131n bir s\u0131n\u0131rlamas\u0131 de\u011fildir. Biyolojinin bir s\u0131n\u0131rlamas\u0131d\u0131r. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"primary-progressive-multiple-sclerosis-a-fundamentally-different-disease-course\">Birincil Progresif Multipl Skleroz: Temelde Farkl\u0131 Bir Hastal\u0131k Seyri<\/h2>\n\n\n\n<p>Birincil progresif MS, ba\u015flang\u0131\u00e7tan itibaren farkl\u0131 bir seyir izler.<\/p>\n\n\n\n<p>Belirgin bir n\u00fcksetme yoktur. \u0130yile\u015fme d\u00f6nemleri yoktur. N\u00f6rolojik fonksiyonlar yava\u015f ve s\u00fcrekli olarak k\u00f6t\u00fcle\u015fir.  <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Enflamasyon daha az belirgindir. <\/li>\n\n\n\n<li>Dejeneratif s\u00fcre\u00e7ler erken d\u00f6nemde bask\u0131nd\u0131r.<\/li>\n\n\n\n<li>MRG bulgular\u0131 genellikle bu fark\u0131 olduk\u00e7a net bir \u015fekilde yans\u0131t\u0131r.<\/li>\n<\/ul>\n\n\n\n<p>Rejeneratif t\u0131p a\u00e7\u0131s\u0131ndan bu durum ciddi bir s\u0131n\u0131rlama yaratmaktad\u0131r.<br>K\u00f6k h\u00fccrelerin veya ekzozomlar\u0131n \u00f6ncelikle etkiledi\u011fi mekanizmalar &#8211; ba\u011f\u0131\u015f\u0131kl\u0131k mod\u00fclasyonu, inflamatuar sinyal iletimi &#8211; burada daha k\u00fc\u00e7\u00fck bir rol oynamaktad\u0131r. Mod\u00fcle edilecek daha az \u015fey vard\u0131r. <\/p>\n\n\n\n<p>PPMS vakalar\u0131n\u0131n \u00e7o\u011funda rejeneratif tedavi uygun de\u011fildir.<br>Her biyolojik se\u00e7enek t\u0131bbi bir zorunluluk de\u011fildir.<\/p>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-100\"><a class=\"wp-block-button__link wp-element-button\" href=\"#requestform\">\u00dccretsiz dan\u0131\u015fmanl\u0131k al\u0131n<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"why-timing-matters-more-than-the-ms-diagnosis-itself\">Zamanlama Neden MS Tan\u0131s\u0131ndan Daha \u00d6nemlidir?<\/h2>\n\n\n\n<p>Hastalar s\u0131kl\u0131kla k\u00f6k h\u00fccre veya ekzozom tedavisinin &#8220;MS i\u00e7in&#8221; uygun olup olmad\u0131\u011f\u0131n\u0131 sorarlar.<br>T\u0131bbi a\u00e7\u0131dan bu soru eksik bir sorudur.<br>\u00d6nemli olan tan\u0131n\u0131n ad\u0131 de\u011fil, hastal\u0131\u011f\u0131n mevcut biyolojik durumudur.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Enflamasyon hala aktif mi?<\/li>\n\n\n\n<li>Hasar hala k\u0131smen geri d\u00f6nd\u00fcr\u00fclebilir mi?<\/li>\n\n\n\n<li>Devam eden ba\u011f\u0131\u015f\u0131kl\u0131k aktivitesinin kan\u0131t\u0131 var m\u0131?<\/li>\n\n\n\n<li>Cevap evet ise, biyolojik destek i\u00e7in bir alan olabilir.<\/li>\n\n\n\n<li>Cevap hay\u0131r ise, genellikle yoktur.<\/li>\n<\/ul>\n\n\n\n<p>Bu genellikle zorlu konu\u015fmalar\u0131n ba\u015flad\u0131\u011f\u0131 and\u0131r.<\/p>\n\n\n\n<p>Bu nedenle, sorumlu programlar a\u00e7\u0131k bir ilke izler:<br>Rejeneratif tedaviler, ancak relaps-remisyon a\u015famas\u0131nda de\u011ferlendirilir.<br>Daha ge\u00e7 de\u011fil.<br>Son \u00e7are olarak de\u011fil.<br>Kan\u0131t olmadan de\u011fil.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"mri-imaging-in-multiple-sclerosis-a-mandatory-requirement-before-any-therapy\">Multipl Sklerozda MRG G\u00f6r\u00fcnt\u00fcleme: Herhangi Bir Tedavi \u00d6ncesi Zorunlu Bir Gereklilik<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"760\" height=\"507\" src=\"https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/MRI-Imaging-Multiple-Sclerosis-Mandatory-Assessment.webp\" alt=\"Multipl sklerozda MRI tabanl\u0131 tan\u0131sal de\u011ferlendirmeyi temsil eden y\u00fcksek kontrastl\u0131 soyut ill\u00fcstrasyon\" class=\"wp-image-182042\" srcset=\"https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/MRI-Imaging-Multiple-Sclerosis-Mandatory-Assessment.webp 760w, https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/MRI-Imaging-Multiple-Sclerosis-Mandatory-Assessment-300x200.webp 300w\" sizes=\"(max-width: 760px) 100vw, 760px\" \/><\/figure>\n\n\n\n<p>Bu konu tart\u0131\u015fmaya a\u00e7\u0131k de\u011fildir.<br>Son zamanlarda \u00e7ekilmi\u015f bir MRG olmadan tedavi uygulanmaz.<br>MRG, a\u015fa\u011f\u0131dakileri anlamak i\u00e7in gereklidir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>iltihaplanma aktif mi<\/li>\n\n\n\n<li>yeni lezyonlar\u0131n veya lezyonlar\u0131n ilerlemesinin olup olmad\u0131\u011f\u0131<\/li>\n\n\n\n<li>ne kadar yap\u0131sal hasar birikmi\u015ftir<\/li>\n\n\n\n<li>hastal\u0131k ortam\u0131n\u0131n biyolojik olarak hala duyarl\u0131 olup olmad\u0131\u011f\u0131<\/li>\n<\/ul>\n\n\n\n<p>MRG g\u00f6r\u00fcnt\u00fcleme olmadan tedavi kararlar\u0131 spek\u00fclatif hale gelir.<br>Spek\u00fclatif t\u0131p burada yeri yoktur.<br>MRG yoksa tedavi de yoktur. \u0130stisnas\u0131z. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"why-stem-cell-therapy-is-discussed-in-multiple-sclerosis\">Neden K\u00f6k H\u00fccre Tedavisi Multipl Sklerozda Tart\u0131\u015f\u0131l\u0131yor?<\/h2>\n\n\n\n<p>MS&#8217;te k\u00f6k h\u00fccre tedavisi genellikle yanl\u0131\u015f anla\u015f\u0131lmaktad\u0131r.<br>Ama\u00e7, n\u00f6ronlar\u0131 de\u011fi\u015ftirmek de\u011fildir.<br>Ama\u00e7, beyni yenilemek de\u011fildir.<\/p>\n\n\n\n<p>Mezenkimal k\u00f6k h\u00fccreler \u00f6ncelikle biyolojik sinyalle\u015fme yoluyla etki ederler. Ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleriyle etkile\u015fime girerler. Enflamatuar yolaklar\u0131 etkilerler. Doku ortamlar\u0131n\u0131n davran\u0131\u015f\u0131n\u0131 etkileyen fakt\u00f6rler salg\u0131larlar.   <\/p>\n\n\n\n<p>MS&#8217;te &#8211; \u00f6zellikle iltihapl\u0131 a\u015famalarda &#8211; bu sinyal verme rol\u00fc t\u00fcm mant\u0131\u011f\u0131n temelini olu\u015fturur.<br>Baz\u0131 hastalar bunun hastal\u0131\u011f\u0131 &#8220;s\u0131f\u0131rlay\u0131p s\u0131f\u0131rlamayaca\u011f\u0131n\u0131&#8221; sorarlar.<br>MS bu \u015fekilde davranmaz.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"exosome-therapy-in-multiple-sclerosis-biological-signaling-rather-than-replacement\">Multipl Sklerozda Ekzozom Tedavisi: Yerine Koyma Yerine Biyolojik Sinyalle\u015fme<\/h2>\n\n\n\n<p><a href=\"https:\/\/medclinics.com\/tr\/ekzozomlar-ve-kok-hucreler-mitler-gercekler-ve-gozden-kacan-sinerji-2\/\" target=\"_blank\" rel=\"noreferrer noopener\">Ekzozomlar<\/a>, h\u00fccreler taraf\u0131ndan sal\u0131nan k\u00fc\u00e7\u00fck keseciklerdir. Di\u011fer h\u00fccreleri etkileyen proteinleri ve genetik sinyalleri ta\u015f\u0131rlar. <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Onlar b\u00f6l\u00fcnmezler.<\/li>\n\n\n\n<li>Onlar greft yapmazlar.<\/li>\n\n\n\n<li>Doku olu\u015fturmazlar.<\/li>\n<\/ul>\n\n\n\n<p>Onlar\u0131 n\u00f6rolojik rahats\u0131zl\u0131klarda \u00f6nemli k\u0131lan \u00f6zellik, kan-beyin bariyerini ge\u00e7ebilme ve merkezi sinir sistemi i\u00e7indeki ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccreleriyle etkile\u015fime girebilme yetenekleridir.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Onlar bir tedavi de\u011fildir.<\/li>\n\n\n\n<li>Onlar bir yedek de\u011fildir.<\/li>\n\n\n\n<li>Onlar biyolojik bir ileti\u015fim arac\u0131d\u0131r.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"when-regenerative-therapy-in-ms-reaches-its-biological-limits\">MS&#8217;te Rejeneratif Tedavi Biyolojik S\u0131n\u0131rlar\u0131na Ula\u015ft\u0131\u011f\u0131nda<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"760\" height=\"507\" src=\"https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/Multiple-Sclerosis-Regenerative-Therapy-with-Stem-Cells-Exosomes.webp\" alt=\"Multipl sklerozda sinir sinyalleri ve rejeneratif h\u00fccre ileti\u015fiminin y\u00fcksek kontrastl\u0131 soyut ill\u00fcstrasyonu\" class=\"wp-image-182046\" srcset=\"https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/Multiple-Sclerosis-Regenerative-Therapy-with-Stem-Cells-Exosomes.webp 760w, https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/Multiple-Sclerosis-Regenerative-Therapy-with-Stem-Cells-Exosomes-300x200.webp 300w\" sizes=\"(max-width: 760px) 100vw, 760px\" \/><\/figure>\n\n\n\n<p>Hastal\u0131\u011f\u0131n ilerlemesi a\u00e7\u0131k\u00e7a g\u00f6r\u00fcld\u00fckten sonra tedavi isteyen hastalar vard\u0131r.<br>T\u0131bbi a\u00e7\u0131dan bak\u0131ld\u0131\u011f\u0131nda, bu a\u015fama genellikle \u00e7ok ge\u00e7 kal\u0131nm\u0131\u015f demektir.<br>Bunun nedeni t\u0131bb\u0131n ba\u015far\u0131s\u0131zl\u0131\u011f\u0131 de\u011fil, biyolojinin s\u0131n\u0131rlar\u0131d\u0131r.<br>Bu s\u0131n\u0131rlar\u0131 kabul etmek, d\u00fcr\u00fcst bak\u0131m\u0131n bir par\u00e7as\u0131d\u0131r.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"which-multiple-sclerosis-patients-may-be-considered-for-regenerative-therapy\">Hangi Multipl Skleroz Hastalar\u0131 Rejeneratif Tedavi i\u00e7in De\u011ferlendirilebilir?<\/h2>\n\n\n\n<p>Dikkatli se\u00e7im \u00e7ok \u00f6nemlidir.<br>Destekleyici rejeneratif tedavi i\u00e7in de\u011ferlendirilen hastalar genellikle:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>MS tan\u0131s\u0131 do\u011frulanm\u0131\u015f<\/li>\n\n\n\n<li>n\u00fckseden-remisyonlu a\u015famadad\u0131r<\/li>\n\n\n\n<li>inflamatuar aktivitenin MRG bulgular\u0131n\u0131 g\u00f6ster<\/li>\n\n\n\n<li>standart tedaviye ra\u011fmen semptomlar devam ediyor<\/li>\n\n\n\n<li>yakla\u015f\u0131m\u0131n s\u0131n\u0131rlar\u0131n\u0131 anlamak<\/li>\n<\/ul>\n\n\n\n<p>Bir\u00e7ok hasta bu kriterleri kar\u015f\u0131lamamaktad\u0131r.<br>Ve bu sorun de\u011fildir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"medical-evaluation-required-before-regenerative-therapy-in-ms\">MS&#8217;de Rejeneratif Tedavi \u00d6ncesi T\u0131bbi De\u011ferlendirme Gereklidir<\/h2>\n\n\n\n<p>Tedavi tart\u0131\u015f\u0131lmadan \u00f6nce, yap\u0131land\u0131r\u0131lm\u0131\u015f bir de\u011ferlendirme yap\u0131lmas\u0131 gerekir. Bu de\u011ferlendirme, n\u00f6rolojik \u00f6yk\u00fc, MRG incelemesi, ila\u00e7 de\u011ferlendirmesi ve beklentilerin tart\u0131\u015f\u0131lmas\u0131n\u0131 i\u00e7erir.<br>Ancak bu \u015fekilde sorumlu bir karar verilebilir. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"how-regenerative-therapy-is-applied-in-clinical-practice\">Rejeneratif Terapi Klinik Uygulamada Nas\u0131l Kullan\u0131l\u0131r?<\/h2>\n\n\n\n<p>Tedavi uygun g\u00f6r\u00fcld\u00fc\u011f\u00fcnde, protokoller ki\u015fiye \u00f6zel olarak d\u00fczenlenir.<br>Genellikle t\u0131bbi g\u00f6zetim alt\u0131nda damar yoluyla k\u00f6k h\u00fccre veya ekzozomlar\u0131n verilmesi s\u00f6z konusudur. \u0130\u015flemler minimal invazivdir ve genellikle iyi tolere edilir. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"safety-and-ethical-standards-in-regenerative-ms-therapy\">Rejeneratif MS Tedavisinde G\u00fcvenlik ve Etik Standartlar<\/h2>\n\n\n\n<p>Sorumlu rejeneratif t\u0131p, s\u0131k\u0131 standartlara uyar: GMP sertifikal\u0131 i\u015fleme, etik kaynakl\u0131 h\u00fccreler, embriyonik k\u00f6k h\u00fccreler kullan\u0131lmaz, kan\u0131tlanmam\u0131\u015f yakla\u015f\u0131mlar kullan\u0131lmaz.<br>G\u00fcvenlik her zaman \u00f6nceliklidir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-ms-patients-may-experience-after-regenerative-therapy\">Rejeneratif Tedavi Sonras\u0131 MS Hastalar\u0131n\u0131n Ya\u015fayabilece\u011fi Deneyimler<\/h2>\n\n\n\n<p>Baz\u0131 hastalar daha az yorgunluk hissettiklerini bildiriyor. Baz\u0131lar\u0131 daha iyi dayan\u0131kl\u0131l\u0131k hissettiklerini belirtiyor. Di\u011ferleri ise \u00e7ok az de\u011fi\u015fiklik fark ediyor. Baz\u0131lar\u0131 ise hi\u00e7bir de\u011fi\u015fiklik fark etmiyor.<br>Bu de\u011fi\u015fkenlik beklenen bir durumdur.<br>Biyoloji tek tip tepki vermez.   <\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"a-clinical-perspective-on-regenerative-therapy-in-multiple-sclerosis\">Multipl Sklerozda Rejeneratif Tedaviye Klinik Bir Bak\u0131\u015f<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Multipl skleroz, zamanlaman\u0131n teknikten daha \u00f6nemli oldu\u011fu bir hastal\u0131kt\u0131r.<\/li>\n\n\n\n<li>Her a\u015fama etkilenemez.<\/li>\n\n\n\n<li>Her hasta tedavi edilmemelidir.<\/li>\n\n\n\n<li>Her se\u00e7enek pe\u015finden gidilmemelidir.<\/li>\n<\/ul>\n\n\n\n<p>Sorumlu bir \u015fekilde kullan\u0131lan rejeneratif t\u0131p, se\u00e7ici ve destekleyici olmaya devam etmektedir.<br>Do\u011fru zamanda kullan\u0131ld\u0131\u011f\u0131nda, biyolojik olarak hala duyarl\u0131 olan bir sistemi stabilize etmeye yard\u0131mc\u0131 olabilir.<br>Yanl\u0131\u015f zamanda kullan\u0131ld\u0131\u011f\u0131nda, sunulmamal\u0131d\u0131r.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"frequently-asked-questions-stem-cell-exosome-therapy-for-copd\">S\u0131k\u00e7a Sorulan Sorular \u2013 MS i\u00e7in K\u00f6k H\u00fccre ve Ekzozom Tedavisi &#8211; Multipl Skleroz<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"760\" height=\"507\" src=\"https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/Multiple-Sclerosis-FAQ-Stem-Cell-Exosome-Therapy.webp\" alt=\"Multipl Skleroz SSS K\u00f6k H\u00fccre Ekzozom Tedavisi\" class=\"wp-image-182072\" srcset=\"https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/Multiple-Sclerosis-FAQ-Stem-Cell-Exosome-Therapy.webp 760w, https:\/\/medclinics.com\/wp-content\/uploads\/2026\/01\/Multiple-Sclerosis-FAQ-Stem-Cell-Exosome-Therapy-300x200.webp 300w\" sizes=\"(max-width: 760px) 100vw, 760px\" \/><\/figure>\n\n\n<div id=\"rank-math-faq\" class=\"rank-math-block\">\n<div class=\"rank-math-list \">\n<div id=\"faq-question-1767031180761\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">K\u00f6k h\u00fccre veya ekzozom tedavisi, n\u00f6rologlar taraf\u0131ndan MS tedavisinde normal olarak kullan\u0131lan bir y\u00f6ntem midir?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Hay\u0131r. Standart tedavi olarak de\u011fil. <br \/>Rutin n\u00f6roloji tedavisinde, multipl skleroz, hastal\u0131\u011f\u0131 modifiye eden ila\u00e7lar, rehabilitasyon ve uzun s\u00fcreli izleme ile tedavi edilir. <br \/>K\u00f6k h\u00fccre veya ekzozom tedavisi bunun yerini almaz. Bu konu tart\u0131\u015f\u0131ld\u0131\u011f\u0131nda, ayr\u0131 olarak ele al\u0131n\u0131r &#8211; genellikle hastalar standart se\u00e7eneklerin \u00f6tesinde ba\u015fka neler oldu\u011funu sorduklar\u0131 i\u00e7in, rutin bir tedavi haline geldi\u011fi i\u00e7in de\u011fil. <\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1767032165091\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Doktorlar genellikle MS&#8217;te rejeneratif tedavi hakk\u0131nda ne zaman konu\u015fmaya ba\u015flarlar?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Erken de\u011fil. Genellikle \u00e7ok daha sonra, hastalar bir s\u00fcre MS ile ya\u015fam\u0131\u015f ve hastal\u0131\u011f\u0131n ne kadar \u00f6ng\u00f6r\u00fclemez olabilece\u011fini g\u00f6rm\u00fc\u015f olduktan sonra.  <br \/>Bu konu\u015fmalar tan\u0131 konuldu\u011funda veya ilk tedavi a\u015famalar\u0131nda g\u00fcndeme gelmez. \u0130ltihap hala mevcutken, ancak standart se\u00e7eneklere kar\u015f\u0131 sab\u0131r t\u00fckenmeye ba\u015flad\u0131\u011f\u0131nda g\u00fcndeme gelir.  <\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1767032184063\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Son zamanlarda MR \u00e7ekilmediyse neden tedaviyi tart\u0131\u015fmay\u0131 reddediyorsunuz?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>\u00c7\u00fcnk\u00fc MRI olmadan tart\u0131\u015f\u0131lacak somut bir \u015fey yoktur. <br \/>MS&#8217;te semptomlar g\u00fcvenilir de\u011fildir. Semptomlar ini\u015fli \u00e7\u0131k\u0131\u015fl\u0131d\u0131r ve hastal\u0131\u011f\u0131n biyolojik olarak ne durumda oldu\u011funu bize g\u00f6stermez. MRG ise g\u00f6sterir.  <br \/>G\u00f6r\u00fcnt\u00fcleme olmadan net bir resim elde edilemez. Net bir resim olmadan ise rejeneratif tedavi hakk\u0131nda konu\u015fmak anlams\u0131zd\u0131r. Dolay\u0131s\u0131yla tart\u0131\u015fma burada sona erer.  <\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1767032200963\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">K\u00f6k h\u00fccreler veya ekzozomlar MS&#8217;te hasarl\u0131 sinirleri ger\u00e7ekten onar\u0131r m\u0131?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>\u00c7o\u011fu insan\u0131n hayal etti\u011fi \u015fekilde de\u011fil. Yap\u0131sal hasar meydana geldikten sonra tahrip olmu\u015f sinir yollar\u0131n\u0131 yeniden in\u015fa etmezler veya kaybedilen fonksiyonlar\u0131 geri kazand\u0131rmazlar.  <br \/>Varsa, bunlar\u0131n rol\u00fc sinyal iletimi ve ba\u011f\u0131\u015f\u0131kl\u0131k mod\u00fclasyonu ile ilgilidir &#8211; yeniden yap\u0131land\u0131rma ile de\u011fil. <br \/>Bu fark, \u00e7o\u011fu hastan\u0131n bekledi\u011finden daha \u00f6nemlidir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1767032375492\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Hastalar bu t\u00fcr bir tedaviden sonra genellikle ne fark ederler?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Tipik bir yan\u0131t yoktur. <br \/>Baz\u0131 hastalar kendilerini daha az yorgun veya daha dengeli hissettiklerini s\u00f6yl\u00fcyorlar. <br \/>Di\u011ferleri ise sadece k\u00fc\u00e7\u00fck de\u011fi\u015fikliklerden bahsediyor. <br \/>Baz\u0131lar\u0131, tedavinin etkisi oldu\u011funu kesin olarak s\u00f6yleyebilecekleri hi\u00e7bir \u015fey fark etmezler. Bu yan\u0131tlar\u0131n \u00e7e\u015fitlili\u011fi normaldir ve a\u00e7\u0131k\u00e7a belirtilmesi gerekir. <\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1767032424142\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">MS i\u00e7in k\u00f6k h\u00fccre veya ekzozom tedavisi i\u00e7in \u00e7ok ge\u00e7 olan bir nokta var m\u0131?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Evet. Biyolojik mod\u00fclasyonun yard\u0131mc\u0131 olmas\u0131n\u0131n olas\u0131 olmad\u0131\u011f\u0131 bir a\u015famaya gelmi\u015f durumlar vard\u0131r. <br \/>\u0130leri evre ilerleyici MS&#8217;te, \u00f6zellikle yap\u0131sal hasar\u0131n bask\u0131n oldu\u011fu durumlarda, rejeneratif tedavi genellikle \u00e7ok az fayda sa\u011flar. Bu durumlarda hay\u0131r demek, t\u0131bb\u0131n ba\u015far\u0131s\u0131zl\u0131\u011f\u0131 anlam\u0131na gelmez.  <br \/>Bu, sorumlu t\u0131bbi karar verme s\u00fcrecinin bir par\u00e7as\u0131d\u0131r.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MS&#8217;i Anlamak \u2013 Multipl Skleroz \u2013 ve Hastalar \u0130\u00e7in Rejeneratif Tedavinin Rol\u00fc Klinik Bulgular Prof. Dr. Serdar Kabata\u015f, MD, PhD [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":182763,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1488,1432,1420,10],"tags":[],"class_list":["post-182764","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kok-hucreler","category-istanbul-tr","category-turkiye","category-uncategorized-tr"],"_links":{"self":[{"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/posts\/182764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/comments?post=182764"}],"version-history":[{"count":2,"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/posts\/182764\/revisions"}],"predecessor-version":[{"id":182768,"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/posts\/182764\/revisions\/182768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/media\/182763"}],"wp:attachment":[{"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/media?parent=182764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/categories?post=182764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medclinics.com\/tr\/wp-json\/wp\/v2\/tags?post=182764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}